Vupanorsen

DB33872InvestigationalGene Therapies

Vupanorsen: Overview.

Mechanism: Pharmacologically active on Angiopoietin-related protein 3
Curator reviewed
Code names: AKCEA-ANGPTL3-LRX · IONIS-ANGPTL3-LRx · ISIS-703802 · PF-07285557

Resolves to

Compound

Targets

What you can answer from here — as of October 05, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vupanorsen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.